372 related articles for article (PubMed ID: 31169990)
1. Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels.
Haechl N; Ebner J; Hilber K; Todt H; Koenig X
Cell Physiol Biochem; 2019; 53(1):36-48. PubMed ID: 31169990
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.
Rubi L; Kovar M; Zebedin-Brandl E; Koenig X; Dominguez-Rodriguez M; Todt H; Kubista H; Boehm S; Hilber K
Toxicol Appl Pharmacol; 2017 Aug; 329():309-317. PubMed ID: 28641963
[TBL] [Abstract][Full Text] [Related]
3. Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.
Koenig X; Kovar M; Rubi L; Mike AK; Lukacs P; Gawali VS; Todt H; Hilber K; Sandtner W
Toxicol Appl Pharmacol; 2013 Dec; 273(2):259-68. PubMed ID: 23707769
[TBL] [Abstract][Full Text] [Related]
4. The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels.
Hackl B; Lukacs P; Ebner J; Pesti K; Haechl N; Földi MC; Lilliu E; Schicker K; Kubista H; Stary-Weinzinger A; Hilber K; Mike A; Todt H; Koenig X
Front Pharmacol; 2022; 13():809802. PubMed ID: 35586063
[No Abstract] [Full Text] [Related]
5. The funny current: cellular basis for the control of heart rate.
DiFrancesco D; Borer JS
Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
[TBL] [Abstract][Full Text] [Related]
6. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels.
Kuryshev YA; Bruening-Wright A; Brown AM; Kirsch GE
J Cardiovasc Pharmacol; 2010 Oct; 56(4):420-30. PubMed ID: 20930594
[TBL] [Abstract][Full Text] [Related]
7. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
Qu Y; Gao B; Fang M; Vargas HM
J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
[TBL] [Abstract][Full Text] [Related]
8. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
Melgari D; Brack KE; Zhang C; Zhang Y; El Harchi A; Mitcheson JS; Dempsey CE; Ng GA; Hancox JC
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25911606
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic Drug Tiagabine Does Not Directly Target Key Cardiac Ion Channels Kv11.1, Nav1.5 and Cav1.2.
Kowalska M; Fijałkowski Ł; Kubacka M; Sałat K; Grześk G; Nowaczyk J; Nowaczyk A
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207748
[TBL] [Abstract][Full Text] [Related]
10. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
[TBL] [Abstract][Full Text] [Related]
11. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.
De Waard S; Montnach J; Ribeiro B; Nicolas S; Forest V; Charpentier F; Mangoni ME; Gaborit N; Ronjat M; Loussouarn G; Lemarchand P; De Waard M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998413
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
13. Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes.
Liu M; Shi G; Zhou A; Rupert CE; Coulombe KLK; Dudley SC
J Mol Cell Cardiol; 2018 Apr; 117():62-71. PubMed ID: 29474817
[TBL] [Abstract][Full Text] [Related]
14. Impact of the DSP-H1684R Genetic Variant on Ion Channels Activity in iPSC-Derived Cardiomyocytes.
Gusev K; Khudiakov A; Zaytseva A; Perepelina K; Makeenok S; Kaznacheyeva E; Kostareva A
Cell Physiol Biochem; 2020 Jul; 54(4):696-706. PubMed ID: 32706220
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment.
Asahi Y; Nomura F; Abe Y; Doi M; Sakakura T; Takasuna K; Yasuda K
Eur J Pharmacol; 2019 Jan; 842():221-230. PubMed ID: 30391349
[TBL] [Abstract][Full Text] [Related]
16. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
[TBL] [Abstract][Full Text] [Related]
17. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling.
Isobe T; Honda M; Komatsu R; Tabo M
J Toxicol Sci; 2019; 44(12):859-870. PubMed ID: 31813905
[TBL] [Abstract][Full Text] [Related]
18. The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo.
Amstetter D; Badt F; Rubi L; Bittner RE; Ebner J; Uhrin P; Hilber K; Koenig X; Todt H
Eur J Pharmacol; 2021 Feb; 893():173818. PubMed ID: 33345856
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Kir2.1 and Na
Ponce-Balbuena D; Guerrero-Serna G; Valdivia CR; Caballero R; Diez-Guerra FJ; Jiménez-Vázquez EN; Ramírez RJ; Monteiro da Rocha A; Herron TJ; Campbell KF; Willis BC; Alvarado FJ; Zarzoso M; Kaur K; Pérez-Hernández M; Matamoros M; Valdivia HH; Delpón E; Jalife J
Circ Res; 2018 May; 122(11):1501-1516. PubMed ID: 29514831
[TBL] [Abstract][Full Text] [Related]
20. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
